Transcription and translation machinery

The transcription and translation machinery refers to the integrated network of enzymes and ribonucleoprotein complexes that execute the central dogma of molecular biology: the conversion of genetic information from DNA to RNA and subsequently to proteins. This system primarily consists of RNA polymerases, which catalyze the synthesis of RNA from a DNA template, and ribosomes, which decode messenger RNA (mRNA) to assemble amino acids into polypeptide chains [Source: National Center for Biotechnology Information (NCBI)]. In clinical practice, this machinery is one of the most significant targets for antimicrobial therapy, where drugs like rifamycins inhibit bacterial RNA synthesis and macrolides or tetracyclines disrupt ribosomal function [Source: StatPearls]. Beyond infectious diseases, the machinery is frequently dysregulated in malignant cells to support rapid proliferation, leading to the development of small-molecule inhibitors targeting RNA polymerase II or specific translation initiation factors as anti-cancer agents [Source: Nature Reviews Drug Discovery]. However, because these processes are fundamental to all life, therapeutic targeting requires high selectivity to avoid systemic toxicity, particularly regarding mitochondrial function [Source: PubMed].

Other names

Protein synthesis machineryGene expression machineryCentral dogma componentsTranslational apparatusTranscriptional apparatus

Inhibition of DNA-dependent RNA polymerase (transcription), or binding to the 30S or 50S ribosomal subunits to inhibit initiation, elongation, or translocation (translation).